2026-10-14T17:32:01Z https://www.scidb.cn/oai

10.57760/sciencedb.17340 2024-12-02T12:58:36Z

2024-12-02 Supplementary Figures and table doi:10.57760/sciencedb.17340 en Supplementary Figures show the changes in serum creatinine levels and HFMSE at 6, 14, and 22 months of noxinaxin treatment, as well as the comparative efficacy of Crn, HFMSE, MRC, and 6MWT in evaluating motor function. Supplementary Table S1 provides the specific values of each patient's assessment and serum creatinine levels for each visit. creatinine; spinal muscular atrophy; biomarker Xin Zhao Min Zhang PUBLIC https://creativecommons.org/publicdomain/zero/1.0/ dataset http://www.doi.org/10.21203/rs.3.rs-4467679/v1 Science Data Bank